Wednesday, September 25, 2013

Noche or Rovartis?

Novartis board member Pierre Landolt said combining Roche and Novartis would make a European "pharmaceutical champion". The combined organisation would employ 1,500 people in this country.

Novartis indicated last month that it was actively looking for a major purchase, up to €7.5bn in value, in its drive to expand. "Novartis would be willing to invest significant money for a very good opportunity. I don't think a $10bn (€7.5bn) acquisition is out of reach" said chairman Joerg Reinhardt.

"Soon both companies will have new chairmen. That might make the dialogue easier," said Mr Landolt, a board member since 1996.

No comments: